5 Key Takeaways
-
1
Dr. Anand Tharmaratnam has been appointed as the new CEO of Novotech, effective January 1, 2026.
-
2
Tharmaratnam has nearly 30 years of experience in the global CRO industry and has served as Novotech Chairman since 2021.
-
3
He will be based at Novotech's new global headquarters in Singapore, reflecting the company's international profile.
-
4
Tharmaratnam aims to expand Novotech's global footprint and strengthen its scientific capabilities in clinical research.
-
5
The company plans to leverage technology and data to support complex biotech programs and deliver innovative outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
